Differential Expression of Secretory Phospholipases A2 in Normal and Malignant Prostate Cell Lines: Regulation by Cytokines, Cell Signaling Pathways, and Epigenetic Mechanisms

Dennis, 1992, Extracellular phospholipase A2, Adv Exp Med Biol, 318, 35, 10.1007/978-1-4615-3426-6_4 Kudo, 2002, Phospholipase A2 enzymes, Prostaglandins Other Lipid Mediat, 68–69, 3, 10.1016/S0090-6980(02)00020-5 Menschikowski, 2006, Secretory phospholipase A2 of group IIA: is it an offensive or a defensive player during atherosclerosis and other inflammatory diseases?, Prostaglandins Other Lipid Mediat, 79, 1, 10.1016/j.prostaglandins.2005.10.005 Kallajoki, 1998, Group II phospholipase A2 in human male reproductive organs and genital tumors, Prostate, 35, 263, 10.1002/(SICI)1097-0045(19980601)35:4<263::AID-PROS5>3.0.CO;2-H Jiang, 2002, Expression of group IIA secretory phospholipase A2 is elevated in prostatic intraepithelial neoplasia and adenocarcinoma, Am J Pathol, 160, 667, 10.1016/S0002-9440(10)64886-9 Sved, 2004, Oncogenic action of secreted phospholipase A2 in prostate cancer, Cancer Res, 64, 6934, 10.1158/0008-5472.CAN-03-3018 Graff, 2001, Expression of group IIa secretory phospholipase A2 increases with prostate tumor grade, Clin Cancer Res, 7, 3857 Morgenbesser, 2007, Identification of genes potentially involved in the acquisition of androgen-independent and metastatic tumor growth in an autochthonous genetically engineered mouse prostate cancer model, Prostate, 67, 83, 10.1002/pros.20505 Yamashita, 1994, Elevation of serum group II phospholipase A2 levels in patients with advanced cancer, Clin Chim Acta, 228, 91, 10.1016/0009-8981(94)90280-1 Gorovetz, 2006, The clinical role of phospholipase A2 isoforms in advanced-stage ovarian carcinoma, Gynecol Oncol, 103, 831, 10.1016/j.ygyno.2006.06.042 Miki, 2007, Butyrate inhibits oral cancer cell proliferation and regulates expression of secretory phospholipase A2-X and COX-2, Anticancer Res, 27, 1493 Kennedy, 1998, Overexpression of the nonpancreatic secretory group II PLA2 messenger RNA and protein in colorectal adenomas from familial adenomatous polyposis patients, Cancer Res, 58, 500 Lagorce-Pagès, 2004, Expression of inflammatory secretory phospholipase A2 and cytosolic phospholipase A2 in premalignant and malignant Barrett's oesophagus, Virchows Arch, 444, 426, 10.1007/s00428-004-1003-7 MacPhee, 1995, The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia, Cell, 81, 957, 10.1016/0092-8674(95)90015-2 Riggins, 1995, Absence of secretory phospholipase A2 gene alterations in human colorectal cancer, Cancer Res, 55, 5184 Dobbie, 1996, Secretory phospholipase A2 does not appear to be associated with phenotypic variation in familial adenomatous polyposis, Hum Genet, 98, 386, 10.1007/s004390050226 Kashiwagi, 1999, Group II and IV phospholipase A2 are produced in human pancreatic cancer cells and influence prognosis, Gut, 45, 605, 10.1136/gut.45.4.605 Leung, 2002, Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis, Proc Natl Acad Sci USA, 99, 16203, 10.1073/pnas.212646299 Dong, 2006, Oncogenic action of phospholipase A2 in prostate cancer, Cancer Lett, 240, 9, 10.1016/j.canlet.2005.08.012 Belinsky, 2007, Expression of secretory phospholipase A2 in colon tumor cells potentiates tumor growth, Mol Carcinog, 46, 106, 10.1002/mc.20271 Lindbom, 2002, Increased gene expression of novel cytosolic and secretory phospholipase A2 types in human airway epithelial cells induced by tumor necrosis factor-α and IFN-γ, J Interferon Cytokine Res, 22, 947, 10.1089/10799900260286650 Yu, 2004, The STATs of cancer—new molecular targets come of age, Nat Rev Cancer, 4, 97, 10.1038/nrc1275 Singh, 2006, Mechanisms of action of novel agents for prostate cancer chemoprevention, Endocr Relat Cancer, 13, 751, 10.1677/erc.1.01126 Corcoran, 2006, Interfering with cellsurvival signalling as a treatment strategy for prostate cancer, BJU International, 97, 1149, 10.1111/j.1464-410X.2006.06198.x Balasoiu, 2005, Cytokines levels in prostate adenocarcinomas, Rom J Morphol Embryol, 46, 179 De Marzo, 2007, Inflammation in prostate carcinogenesis, Nat Rev Cancer, 7, 256, 10.1038/nrc2090 Yoshimura, 2006, Signal transduction of inflammatory cytokines and tumor development, Cancer Sci, 97, 439, 10.1111/j.1349-7006.2006.00197.x Menschikowski, 2005, Statins potentiate the IFN-γ induced upregulation of group IIA phospholipase A2 in human aortic smooth muscle cells and HepG2 hepatoma cells, Biochim Biophys Acta, 1733, 157, 10.1016/j.bbalip.2005.01.001 Crowl, 1990, Isolation and characterisation of cDNA clones from human placenta coding for phospholipase A2, Adv Exp Med Biol, 279, 173, 10.1007/978-1-4613-0651-1_11 Ercolani, 1988, Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene, J Biol Chem, 263, 15335, 10.1016/S0021-9258(19)37593-3 Andreani, 2000, Transcriptional regulation of inflammatory secreted phospholipases A2, Biochim Biophys Acta, 1488, 149, 10.1016/S1388-1981(00)00117-7 Webber, 1997, Immortalized and tumorigenic adult human prostatic epithelial cell lines: characteristics and applications: Part 3. Oncogenes, suppressor genes, and applications, Prostate, 30, 136, 10.1002/(SICI)1097-0045(19970201)30:2<136::AID-PROS9>3.0.CO;2-M Engl, 2006, Prostate tumor CXC-chemokine profile correlates with cell adhesion to endothelium and extracellular matrix, Life Sci, 78, 1784, 10.1016/j.lfs.2005.08.019 Aalinkeel, 2004, Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells, Cancer Res, 64, 5311, 10.1158/0008-5472.CAN-2506-2 Dunn, 2005, IFN unresponsiveness in LNCaP cells due to the lack of JAK1 gene expression, Cancer Res, 65, 3447, 10.1158/0008-5472.CAN-04-4316 Yang, 2006, Role of the CCAAT/enhancer-binding protein NFATc2 transcription factor cascade in the induction of secretory phospholipase A2, J Biol Chem, 281, 11541, 10.1074/jbc.M511214200 Cookson, 1997, Glutathione S-transferase PI (GST-pi) class expression by immunohistochemistry in benign and malignant prostate tissue, J Urol, 157, 673, 10.1016/S0022-5347(01)65248-0 Millar, 1999, Detailed methylation analysis of the glutathione S-transferase pi (GSTP1) gene in prostate cancer, Oncogene, 18, 1313, 10.1038/sj.onc.1202415 Lodygin, 2005, Functional epigenomics identifies genes fre Ruently silenced in prostate cancer, Cancer Res, 65, 4218, 10.1158/0008-5472.CAN-04-4407 Chetcuti, 2001, Loss of annexin II heavy and light chains in prostate cancer and its precursors, Cancer Res, 61, 6331 Nelson, 2007, Abnormal DNA methylation, epigenetics, and prostate cancer, Front Biosci, 12, 4254, 10.2741/2385 Ben-Hattar, 1988, Methylation of single CpG dinucleotides within a promoter element of the Herpes simplex virus tk gene reduces its transcription in vivo, Gene, 65, 219, 10.1016/0378-1119(88)90458-1 Xin, 2007, FTY720 suppresses interleukin-1β-induced secretory phospholipase A2 expression in renal mesangial cells by a transcriptional mechanism, Br J Pharmacol, 150, 943, 10.1038/sj.bjp.0707171 Scholz, 1999, Modulation of cytokine-induced expression of secretory phospholipase A2-type IIA by protein kinase C in rat renal mesangial cells, Biochem Pharmacol, 58, 1751, 10.1016/S0006-2952(99)00279-8 Tanaka, 2003, Protein kinase C promotes apoptosis in LNCaP prostate cancer cells through activation of p38 MAPK and inhibition of the Akt survival pathway, J Biol Chem, 278, 33753, 10.1074/jbc.M303313200 Murakami, 1998, The functions of five distinct mammalian phospholipase A2s in regulating arachidonic acid release. Type IIa and type V secretory phospholipase A2s are functionally redundant and act in concert with cytosolic phospholipase A2, J Biol Chem, 273, 14411, 10.1074/jbc.273.23.14411 Bernatchez, 2001, VEGF stimulation of endothelial cell PAF synthesis is mediated by group V 14 kDa secretory phospholipase A2, Br J Pharmacol, 134, 197, 10.1038/sj.bjp.0704215 Tessier, 2002, Implication of three isoforms of PLA2 in human T-cell proliferation, FEBS Lett, 520, 111, 10.1016/S0014-5793(02)02779-5